Arrowstreet Capital’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.9M | Buy |
308,046
+236,566
| +331% | +$16.2M | 0.01% | 726 |
|
|
2025
Q4 | $4.23M | Sell |
71,480
-83,811
| -54% | -$4.55M | ﹤0.01% | 1185 |
|
|
2025
Q3 | $8.57M | Buy |
+155,291
| New | +$8.08M | 0.01% | 1003 |
|
|
2024
Q3 | – | Sell |
-9,535
| Closed | -$417K | – | 1825 |
|
|
2024
Q2 | $417K | Sell |
9,535
-12,734
| -57% | -$615K | ﹤0.01% | 1359 |
|
|
2024
Q1 | $1.06M | Buy |
+22,269
| New | +$1M | ﹤0.01% | 1306 |
|
|
2023
Q3 | – | Sell |
-24,460
| Closed | -$1.42M | – | 1366 |
|
|
2023
Q2 | $1.42M | Sell |
24,460
-29,668
| -55% | -$1.78M | ﹤0.01% | 907 |
|
|
2023
Q1 | $3.87M | Buy |
54,128
+39,727
| +276% | +$3.15M | 0.01% | 753 |
|
|
2022
Q4 | $1.01M | Buy |
+14,401
| New | +$1.02M | ﹤0.01% | 1023 |
|
|
2022
Q2 | – | Sell |
-174,452
| Closed | -$11.2M | – | 1356 |
|
|
2022
Q1 | $11.2M | Sell |
174,452
-164,603
| -49% | -$11M | 0.01% | 502 |
|
|
2021
Q4 | $24.3M | Sell |
339,055
-42,808
| -11% | -$3.26M | 0.03% | 431 |
|
|
2021
Q3 | $27.3M | Buy |
381,863
+181,245
| +90% | +$14.3M | 0.03% | 445 |
|
|
2021
Q2 | $16.3M | Buy |
200,618
+135,621
| +209% | +$10.9M | 0.02% | 683 |
|
|
2021
Q1 | $4.91M | Sell |
64,997
-147,475
| -69% | -$10.7M | 0.01% | 1183 |
|
|
2020
Q4 | $16.1M | Sell |
212,472
-173,837
| -45% | -$11.3M | 0.02% | 677 |
|
|
2020
Q3 | $19.1M | Buy |
386,309
+63,524
| +20% | +$3.58M | 0.03% | 570 |
|
|
2020
Q2 | $17M | Buy |
322,785
+63,798
| +25% | +$3.03M | 0.03% | 569 |
|
|
2020
Q1 | $9.12M | Buy |
258,987
+147,818
| +133% | +$8.63M | 0.03% | 515 |
|
|
2019
Q4 | $9.71M | Buy |
111,169
+24,273
| +28% | +$2.12M | 0.02% | 616 |
|
|
2019
Q3 | $7.37M | Buy |
+86,896
| New | +$7.74M | 0.02% | 588 |
|
|
2019
Q2 | – | Sell |
-42,603
| Closed | -$4.5M | – | 1597 |
|
|
2019
Q1 | $4.5M | Buy |
42,603
+36,476
| +595% | +$3.66M | 0.01% | 828 |
|
|
2018
Q4 | $513K | Buy |
+6,127
| New | +$555K | ﹤0.01% | 1083 |
|
|
2018
Q3 | – | Sell |
-69,405
| Closed | -$5.61M | – | 1194 |
|
|
2018
Q2 | $5.61M | Sell |
69,405
-90,540
| -57% | -$7.2M | 0.01% | 520 |
|
|
2018
Q1 | $11.8M | Buy |
159,945
+39,682
| +33% | +$2.97M | 0.03% | 412 |
|
|
2017
Q4 | $8.47M | Buy |
120,263
+91,863
| +323% | +$6.63M | 0.02% | 479 |
|
|
2017
Q3 | $1.77M | Buy |
28,400
+22,600
| +390% | +$1.34M | ﹤0.01% | 728 |
|
|
2017
Q2 | $333K | Buy |
+5,800
| New | +$341K | ﹤0.01% | 929 |
|
|
2016
Q4 | – | Sell |
-74,819
| Closed | -$3.45M | – | 2249 |
|
|
2016
Q3 | $3.45M | Buy |
74,819
+40,680
| +119% | +$1.72M | 0.01% | 760 |
|
|
2016
Q2 | $1.16M | Buy |
+34,139
| New | +$1.07M | ﹤0.01% | 986 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
Arrowstreet Capital's NGVT Position: Q1 2026 in Review
Arrowstreet Capital increased its Ingevity (NGVT) stake by 331% in Q1 2026, buying an estimated $16.2M and bringing the position to 308,046 shares worth $21.9M. The position accounts for 0.01% of the portfolio, ranked #726.
Arrowstreet Capital first reported a position in NGVT in Q2 2016 and has held it in 28 quarters since. The position peaked at $27.3M in Q3 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Arrowstreet Capital held 308,046 shares of Ingevity worth $21.9M as of Q1 2026.
- Arrowstreet Capital bought 236,566 Ingevity shares in Q1 2026, an estimated $16.2M.
- Ingevity made up 0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #726 holding.
- Arrowstreet Capital first reported a position in Ingevity in Q2 2016 and has held it in 28 quarters since.
- Arrowstreet Capital's Ingevity position peaked at $27.3M in Q3 2021.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.